Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim O'Connor

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Protein Expression and Purification|February 10, 2004
Overexpression and rapid purification of Escherichia coli formamidopyrimidine-DNA glycosylasePrasad Reddy, Pawel Jaruga, Tim O'Connor, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|June 24, 2006
Geometric subspace methods and time-delay embedding for EEG artifact removal and classificationCharles W Anderson, James N Knight, Tim O'Connor, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|October 19, 2010
Accentuated cortico-cortical evoked potentials in neocortical epilepsy in areas of ictal onsetMasaki Iwasaki, Rei Enatsu, Riki Matsumoto, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
The Impact of Conventional Stroke Risk Factors on Early and Late Onset Ischemic Stroke: a Mendelian Randomization StudyKevin Tk Nguyen, Huichun Xu, Brady Gaynor, et al.
Blood Advances|December 21, 2021
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AMLAmer M Zeidan, Isaac Boss, C L Beach, et al.
Blood Advances|December 31, 2021
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromesAmer M Zeidan, Isaac Boss, C L Beach, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Protein Expression and Purification|February 10, 2004
Overexpression and rapid purification of Escherichia coli formamidopyrimidine-DNA glycosylasePrasad Reddy, Pawel Jaruga, Tim O'Connor, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|June 24, 2006
Geometric subspace methods and time-delay embedding for EEG artifact removal and classificationCharles W Anderson, James N Knight, Tim O'Connor, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|October 19, 2010
Accentuated cortico-cortical evoked potentials in neocortical epilepsy in areas of ictal onsetMasaki Iwasaki, Rei Enatsu, Riki Matsumoto, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
The Impact of Conventional Stroke Risk Factors on Early and Late Onset Ischemic Stroke: a Mendelian Randomization StudyKevin Tk Nguyen, Huichun Xu, Brady Gaynor, et al.
Blood Advances|December 21, 2021
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AMLAmer M Zeidan, Isaac Boss, C L Beach, et al.
Blood Advances|December 31, 2021
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromesAmer M Zeidan, Isaac Boss, C L Beach, et al.
Pageof 1